about
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.Frequent mismatch-repair defects link prostate cancer to Lynch syndromeFamilial colorectal cancer type X: genetic profiles and phenotypic features.Deranged Wnt signaling is frequent in hereditary nonpolyposis colorectal cancer.Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2.Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair proteinGain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types.Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome.[Danish Lynch syndrome families].Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.Distinct gene expression signatures in Lynch syndrome and familial colorectal cancer type XImmunoprofiles of colorectal cancer from Lynch syndromeSarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrumAn effect from anticipation also in hereditary nonpolyposis colorectal cancer families without identified mutationsRenal cell cancer linked to Lynch syndrome: Increased incidence and loss of mismatch repair protein expression
P50
Q27852988-D8D362A3-F012-4385-A40E-DDBACA61247AQ34950524-AC4EAB81-5748-4F1D-AA7F-E54350E32E3CQ35969934-7042789C-CA59-4B0B-B12C-E28FE37A33BFQ38205339-38BC8462-A25F-48CB-844D-C67C0B3B2C04Q39809521-0BF756AD-2835-4BAB-AF47-5DA50B6DD00BQ41345672-BEBCFA2E-7755-4175-AFC9-DA227640F9C6Q41373360-F4D86F3D-A7C7-4892-B20F-0D67A989E09BQ42752425-31BD07C9-511D-4A1C-ADC4-D61F83158FC9Q44608514-0276AB89-CABD-404E-A230-575B139208E1Q47729288-64457A8A-3170-44E8-8202-604A89EAD248Q48345663-E925F4EC-FD87-44B3-AE1F-F45B8712B794Q50547764-CBBB4C5C-4D3B-469E-8F21-9224CB4AD7E8Q50556962-1472B0CD-A54B-4E30-8FD5-0C158F1FE023Q50569587-E0B35563-DC13-4A16-970E-E508264D6E47Q59850232-F7406833-0382-4468-840E-433585AD8045Q63729383-93FBB41E-D16F-4A97-A436-AED618CD0867Q83159492-BE19DF00-8CD5-4F5D-952F-B6DB5566A414Q84550141-A2E3FA2A-01CA-4329-9C01-E5CBF460F419Q89413223-EDF6F2A9-3273-4CB3-BF19-19375A70090E
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-2833-6986
@en
name
Christina Therkildsen
@ast
Christina Therkildsen
@en
Christina Therkildsen
@es
Christina Therkildsen
@nl
type
label
Christina Therkildsen
@ast
Christina Therkildsen
@en
Christina Therkildsen
@es
Christina Therkildsen
@nl
prefLabel
Christina Therkildsen
@ast
Christina Therkildsen
@en
Christina Therkildsen
@es
Christina Therkildsen
@nl
P106
P108
P21
P31
P496
0000-0002-2833-6986